Background: To compare the rate of recovery of motor and functional ability and heart rate variability (HRV) parameters during the inpatient rehabilitation period. Summary: Twenty-three patients post first stroke at the sub-acute phase underwent motor and functional ability and HRV assessments 20 and 50 days after the event. A significant improvement was noted in motor and functional ability performance during the follow-up period, while no such change was noted in the HRV parameters. Key Messages: Patients post first-ever stroke exhibited a significant motor and functional improvement during the sub-acute phase post stroke, while no change was noted in their HRV parameters, which may imply that no significant changes in the sympatho-vagal balance took place during this period.

Keywords:
Autonomic, Heart rate variability, Walking, Stroke
1.
Rand D, Eng JJ, Tang PF, Jeng JS, Hung C: How active are people with stroke?: use of accelerometers to assess physical activity. Stroke 2009;40:163-168.
2.
Ryan AS, Dobrovolny CL, Silver KH, Smith GV, Macko RF: Cardiovascular fitness after stroke: role of muscle mass and gait deficit severity. J Stroke Cerebrovasc Dis 2000;9:185-191.
3.
Diserens K, Vuadens P, Michel P, Reichhart M, Herrmann FR, Arnold P, Bogousslavsky J, Ghika J: Acute autonomic dysfunction contralateral to acute strokes: a prospective study of 100 consecutive cases. Eur J Neurol 2006;13:1245-1250.
4.
Sörös P, Hachinski V: Cardiovascular and neurological causes of sudden death after ischaemic stroke. Lancet Neurol 2012;11:179-188.
5.
Xiong L, Leung H, Chen XY, Han JH, Leung T, Soo Y, et al: Preliminary findings of the effects of autonomic dysfunction on functional outcome after acute ischemic stroke. Clin Neurol Neurosurg 2012;114:316-320.
6.
Bassi A, Colivicchi F, Santini M, Caltagirone C: Cardiac autonomic dysfunction and functional outcome after ischaemic stroke. Eur J Neurol 2007;14:917-922.
7.
Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996;17:354-381.
8.
Beninato M, Gill-Body KM, Salles S, Stark PC, Black-Schaffer RM, Stein J: Determination of the minimal clinically important difference in the FIM instrument in patients with stroke. Arch Phys Med Rehabil 2006;87:32-39.
9.
Fulk GD, Echternach JL, Nof L, O'Sullivan S: Clinometric properties of the six-minute walk test in individuals undergoing rehabilitation poststroke. Physiother Theory Pract 2008;24:195-204.
10.
Gamelin FX, Berthoin S, Bosquet L: Validity of the polar S810 heart rate monitor to measure R-R intervals at rest. Med Sci Sports Exerc 2006;38:887-893.
11.
Riddle DL, Finucane SD, Rothstein JM, Walker ML: Intrasession and intersession reliability of hand-held dynamometer measurements taken on brain-damaged patients. Phys Ther 1989;69:182-194.
12.
Katz-Leurer M, Fisher I, Neeb M, Schwartz I, Carmeli E: Reliability and validity of the modified functional reach test at the sub-acute stage post-stroke. Disabil Rehabil 2009;31:243-248.
13.
West T, Bernhardt J: Physical activity in hospitalised stroke patients. Stroke Res Treat 2012.
14.
Raimundo RD, de Abreu LC, Adami F, Vanderlei FM, de Carvalho TD, et al: Heart rate variability in stroke patients submitted to an acute bout of aerobic exercise. Transl Stroke Res 2013;4:488-499.
15.
Katz-Leurer M, Zohar N, Boum A, Keren O: Monitoring changes in heart rate, as an indicator of the cardiovascular autonomic nervous function, among patients at the sub-acute phase post-brain damage during a physiotherapy session: a preliminary investigation. Brain Inj 2014;28:127-131.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.